LCTX
Lineage Cell Therapeutics Inc
0.9042$
-5.4%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +30.2% | -11.1% | -20.4% | -21.0% | +4.4% | -47.7% | +404.0% | +277.4% | -39.2% | +6.2% | +53.2% | |
| – | +32.2% | -67.7% | -53.1% | +79.8% | +36.4% | -6.6% | +270.4% | -48.9% | -7.8% | -50.2% | +153.0% | |
| – | +28.6% | +32.7% | -14.3% | -31.4% | -4.3% | -63.6% | +536.6% | +465.8% | -40.8% | +10.8% | +49.6% | |
| – | +13.5% | -15.3% | -33.5% | -12.8% | -14.3% | -31.4% | +175.3% | -58.8% | +12.3% | -20.6% | +42.2% | |
| – | +65.9% | -2.4% | -29.9% | +24.1% | -2.8% | -35.2% | +17.0% | +23.6% | -23.1% | +5.0% | +1.6% | |
| – | +29.8% | -9.5% | -30.5% | -0.4% | -5.1% | -32.8% | +92.6% | -29.4% | -9.6% | -7.2% | +15.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +273.4% | +119.7% | -7.4% | +1,471.1% | -84.5% | +206.4% | -100.0% | +258,950.0% | – | – | – | |
| – | – | – | -225.1% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -433.3% | – | -19,040.7% | |
| – | – | – | -159.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.